PBPatrick Bédard

Patrick Bédard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Patrick Bédard has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Christophe Caneparo

    Department of Pediatrics, Gynecology and Obstetrics, Faculty of Medicine, Geneva University Hospitals, University of Geneva, CH-1205 Geneva, Switzerland

    1 shared publication
  • Karel Ferland

    The Tissue Engineering Laboratory (LOEX), Université Laval’s Research Center, Quebec, QC G1V 0A6, Canada

    1 shared publication
  • Sara Gauvin

    Centre de Recherche en Organogénèse Expérimentale de l’Université Laval/LOEX, Centre de Recherche du CHU de Québec-Université Laval, Axe Médecine Régénératrice, Québec, QC G1J 1Z4, Canada

    1 shared publication
  • Stéphane Bolduc

    Centre de Recherche en Organogénèse Expérimentale/LOEX, CHU de Québec-Université Laval Research Center (Regenerative Medicine Division), Université Laval, Quebec City, QC G1J 4A4, Canada

    1 shared publication
  • Stéphane Chabaud

    Centre de Recherche en Organogénèse Expérimentale/LOEX, CHU de Québec-Université Laval Research Center (Regenerative Medicine Division), Université Laval, Quebec City, QC G1J 4A4, Canada

    1 shared publication
  • Ève Pellerin

    Centre de Recherche en Organogénèse Expérimentale/LOEX, Regenerative Medicine Division, CHU de Québec-Université Laval Research Center, Québec, QC G1J 1Z4, Canada

    1 shared publication

Latest Publications

  • Open Access

    Innovative Human Three-Dimensional Tissue-Engineered Models as an Alternative to Animal Testing

    by Patrick Bédard, Sara Gauvin, Karel Ferland, Christophe Caneparo, Ève Pellerin, Stéphane Chabaud, Stéphane Bolduc

    Animal testing has long been used in science to study complex biological phenomena that cannot be investigated using two-dimensional cell cultures in plastic dishes. With time, it appeared that more differences could exist between animal models and even more when translated to human patients. Innovative models became essential to develop more accurate knowledge. Tissue engineering provides some of those models, but it mostly relies on the use of prefabricated scaffolds on which cells are seeded. The self-assembly protocol has recently produced organ-specific human-derived three-dimensional models without the need for exogenous material. This strategy will help to achieve the 3R principles.